We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+31.99%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$150M
AUM Growth
-$13.9M
Cap. Flow
-$14M
Cap. Flow %
-9.29%
Top 10 Hldgs %
87.74%
Holding
32
New
6
Increased
8
Reduced
10
Closed
5

Top Buys

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$12.2M
2
ARDX icon
Ardelyx
ARDX
+$10.1M
3
WGS icon
GeneDx Holdings
WGS
+$5.69M
4
BHVN icon
Biohaven
BHVN
+$4.38M
5
EYPT icon
EyePoint Inc
EYPT
+$1.49M

Sector Composition

Rank Sector Weight
1 Healthcare 81.72%
2 Consumer Discretionary 0.82%
3 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXDX
26
DELISTED
Accelerate Diagnostics
AXDX
$41.7K 0.03%
42,101
-69,474
-62% -$110K
DMTK
27
DELISTED
DermTech, Inc. Common Stock
DMTK
$33.5K 0.02%
47,687
INKT icon
28
MiNK Therapeutics
INKT
$54.6M
-3,690
Closed -$39.5K
QDEL icon
29
CALL
QuidelOrtho
QDEL
$838M
-172,100
Closed -$12.7M
TDOC icon
30
CALL
Teladoc Health
TDOC
$1.3B
-639,600
Closed -$13.8M
TDOC icon
31
Teladoc Health
TDOC
$1.3B
-112,861
Closed -$2.43M
VTNR
32
DELISTED
Vertex Energy, Inc
VTNR
-50,000
Closed -$170K

Similar funds

Oracle Investment Management's Q1 2024 Portfolio in Review

As of Q1 2024, Oracle Investment Management held 32 positions worth $150M, down 8.5% from $164M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Oracle Investment Management withdrew a net $14M in Q1 2024, closing 5 positions and reducing 10 holdings. Its most notable exit was Teladoc Health, an estimated $2.43M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, up from 56% a quarter earlier, followed by Consumer Discretionary and Energy.

Against the trend, Oracle Investment Management opened a new position in CAVA Group worth $1.23M.

  • Oracle Investment Management's largest Q1 2024 buy was CAVA Group: 17,600 shares worth $1.23M.
  • Oracle Investment Management added most to SpringWorks Therapeutics in Q1 2024, an estimated $12.2M increase.
  • Oracle Investment Management's biggest Q1 2024 reduction was QuidelOrtho, cutting an estimated $1.13M.
  • Oracle Investment Management fully exited Teladoc Health in Q1 2024, selling an estimated $2.43M.
  • Oracle Investment Management's ten largest holdings make up 88% of its $150M portfolio in Q1 2024.
  • Oracle Investment Management opened 6 new positions and closed 5 in Q1 2024.
  • Oracle Investment Management's portfolio value fell 8.5% quarter-over-quarter to $150M.

Based on Oracle Investment Management's 13F filing for Q1 2024, filed 15 May 2024.